Showing 1 - 10 results of 10 for search 'Rolf A Brekken', query time: 0.02s
Refine Results
-
1
Perspectives on Hypoxia Signaling in Tumor Stroma by Yuqing Zhang, Morgan Coleman, Rolf A. Brekken
Published 2021-06-01
Article -
2
VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer by Kristi D. Lynn, Christina L. Roland, Rolf A. Brekken
Published 2010-05-01
Article -
3
CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target by Shivani Malik, Jill M. Westcott, Rolf A. Brekken, Francis J. Burrows
Published 2021-12-01
Article -
4
-
5
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis by Raghav Chandra, John D. Karalis, Charles Liu, Gilbert Z. Murimwa, Josiah Voth Park, Christopher A. Heid, Scott I. Reznik, Emina Huang, John D. Minna, Rolf A. Brekken
Published 2021-12-01
Article -
6
598 Bemcentinib + pembrolizumab show promising efficacy in metastatic NSCLC harbouring mutations associated with poor prognosis: exploratory sub-analysis from the BGBC008 trial (NC... by Michael Chisamore, Noelly Madeleine, Austin Rayford, Gro Gausdal, David R Micklem, Magnus Blø, Dina Alzhanova, Josephine Amalia Taverna, Chia-Nung Hung, Rolf A Brekken, Claudia Gorcea-Carson, Cristina Oliva, Nigel McCracken
Published 2023-11-01Article -
7
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer by Huocong Huang, Yuqing Zhang, Valerie Gallegos, Noah Sorrelle, Mohamed Medhat Zaid, Jason Toombs, Wenting Du, Steven Wright, Moriah Hagopian, Zhaoning Wang, Abdel Nasser Hosein, Adwait Amod Sathe, Chao Xing, Eugene J Koay, Kyla E Driscoll, Rolf A Brekken
Published 2019-11-01
Article -
8
Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer by Niklas Krebs, Lukas Klein, Florian Wegwitz, Elisa Espinet, Hans Carlo Maurer, Mengyu Tu, Frederike Penz, Stefan Küffer, Xingbo Xu, Hanibal Bohnenberger, Silke Cameron, Marius Brunner, Albrecht Neesse, Uday Kishore, Elisabeth Hessmann, Andreas Trumpp, Philipp Ströbel, Rolf A. Brekken, Volker Ellenrieder, Shiv K. Singh
Published 2022-08-01
Article -
9
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression by Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P. El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D. Foulkes, Diane R. Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A. Brekken, Lars A. Akslen, Randolph S. Watnick
Published 2022-12-01
Article -
10
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial by David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, Jay Lohrey, Syed M. Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, Ellen Siglinsky, Anil K. Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura Benjamin, Rolf A. Brekken, Chul Ahn, Amit G. Singal, Hao Zhu, Yujin Hoshida, Adam C. Yopp
Published 2024-03-01
Article